West Pharmaceutical Services Inc. (NYSE: WST) is a healthcare company, listed on the NYSE. Alpha Stocks Insight has published 2 articles on WST since Thursday, July 2, 2026, most recently "West Pharmaceutical Services (NYSE: WST) Renews 10-Year Licensing and Distribution Pact With Daikyo Seiko" on Tuesday, July 14, 2026. Coverage to date spans Health Care, tracking WST's earnings, analyst activity, and material corporate events. New coverage is added each trading day.
WST just renewed its technology crosslicense and exclusive distribution deal with Daikyo Seiko, extending a partnership that covers pharma packaging know-how across all markets outside Japan.
West Pharmaceutical closed the sale of SmartDose 3.5mL on-body delivery system rights on July 1, shedding a manufacturing unit in a planned divestiture.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.
Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.